Conditions: Type 2 Diabetes
Keywords: Type 2 diabetes HbA1c Long-term study
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 136
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the long-term safety and efficacy of KAD-1229 as combination therapy with biguanide or DPP-4 inhibitor in type 2 diabetes patients who show inadequate glycemic control with diet, and biguanide or DPP-4 inhibitor monotherapy.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: KAD-1229
Intervention descriptions: intervention 1: None

Protocol document: